NEW YORK (GenomeWeb News) – Horizon Discovery announced today a research service agreement to deploy its X-MAN isogenic cell lines in support of Blueprint Medicine's "New Targets" discovery platform.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.
Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.
Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.
By analyzing tweets, Canadian researchers examine the public's view of gene patenting.
In this online seminar, Jo Vandesompele of the Center for Medical Genetics at Ghent University will discuss methods for improving the analysis of microRNA expression from a range of samples.
This online seminar will outline a targeted enrichment technology to improve next-generation sequencing assays for cancer research and clinical applications.
This webinar will highlight the key considerations and applications of next-generation sequencing for managing non-small cell lung cancer patients using plasma-based approaches.